GCS Resources - Page 2 of 3 - The GCS Project

The GCS Project is a 501c3 Organization

(updated 1/27/18) The GCS Project has received approval from the IRS to become a 501(c)(3)!    Why is it important for The GCS Project to become a 501c3?    Obtaining 501c3 status enables the GCS Project to become eligible for grants and other public and private allocations available only to IRS-recognized,501(c)(3) organizations. In addition, when and organization has obtained […]


Posted: August 8, 2017 | View More »


Thank You Kevin! $5500 Raised for GCS

  On May 7th, Kevin Schieferstein ran the Pittsburgh Marathon to raise money for the GCS Project. He raised $5500! Kevin, we cannot thank you enough for your support. What an amazing run!  


Posted: May 11, 2017 | View More »


Second Opinions for GYN Carcinosarcoma (MMMT) with Dr. Marcela del Carmen (Part 9) [VIDEO]

Patient/advocate Diane Redington and Dr. Marcela del Carmen discuss the importance of being armed with as much information as possible in fighting gynecological carcinosarcoma. This is the ninth video of our nine-part series.   Dr. Marcela del Carmen explains that patients live longer when being treated by doctors that are true experts in GYN carcinosarcoma […]


Posted: May 9, 2017 | View More »


Advocacy with GYN Carcinosarcoma (MMMT) with Dr. Marcela del Carmen (Part 8) [VIDEO]

Patient/advocate Diane Redington and Dr. Marcela del Carmen discuss the importance of clinical trials and the extreme lack of funding for gynecological cancer research. This is part eight of a nine-part series. Dr. Marcela del Carmen explains that the field is on the forefront of major discoveries in understanding the biology of this carcinosarcoma; however, […]


Posted: May 7, 2017 | View More »


Diagnosis and Treatment with Dr. Marcela del Carmen (Part 7) [VIDEO]

Patient/advocate Diane Redington and Dr. Marcela del Carmen discuss diagnosis and treatment of gynecological carcinosarcoma (MMMT). This is part seven of a nine-part series. Dr. Marcela del Carmen discusses how gynecological carcinosarcoma is different than ovarian or uterine cancers. It is very important to get an accurate diagnosis from an expert to confirm exactly what […]


Posted: May 5, 2017 | View More »


How to Find a Clinical Trial with Dr. Whitfield Growden (Part 6) [VIDEO]

Patient/Advocate Diane Redington and Dr. Whitfield Growden discuss availability, eligibility and decisions regarding clinical trials and the differences in treatment options. This is part six of a nine-part series. Dr. Growden explains that carcinosarcomas are generally excluded from clinical trials, although uterine carcinosarcoma has been allowed in some trials. Soon, they are going to be […]


Posted: April 29, 2017 | View More »


Genome Analysis and Immunotherapy with Dr. Whitfield Growden (Part 5) [VIDEO]

Patient/Advocate Diane Redington and Dr. Whitfield Growden discuss genomic analysis, patterns of resistance, and immunotherapy. This is part five of a nine-part series. Dr. Growden discusses tumor specimens used for genomic analysis and the impact of tumor changes. Recognizing patterns of resistance is very important for treatment. Also discussed is a type of immunotherapy called […]


Posted: April 27, 2017 | View More »


Diagnosis and Treatment of Gyn Carcinosarcoma (MMMT) with Dr. Whitfield Growden (Part 4) [VIDEO]

Patient/advocate Diane Redington and Dr. Whitfield Growden discuss the management of ovarian and uterine carcinosarcoma. This is part four of a nine-part series. Dr. Growden discusses important differences between ovarian and uterine carcinosarcoma and takes us through the stages and treatment modalities for each at the various stages. Chemotherapy, including intraperitoneal chemotherapy, and radiation is […]


Posted: April 24, 2017 | View More »


Research and Clinical Trials with Dr. Whitfield Growden (Part 3) [VIDEO]

Patient/advocate Diane Redington and Dr. Whitfield Growden discuss current scientific findings and clinical trials in ovarian and uterine carcinosarcoma. This is part three of a nine-part series. Dr. Growden discusses how they have examined tumors (from Mass General’s tumor bank) of the ovary, uterus, fallopian tubes, and vagina. They found approximately 150 different mutations and […]


Posted: April 20, 2017 | View More »


Research (Part 2) with Dr. Michael Birrer [VIDEO]

Patient/advocate, Diane Redington and Dr. Michael Birrer discuss the results of GCS Project research to-date and where the research is headed. This is part two of a nine-part series. Dr. Birrer discusses the fact that doctors typically treat ovarian carcinosarcoma the same as ovarian cancer, but they are NOT the same, and they should not […]


Posted: April 18, 2017 | View More »